Where does Diya Malhotra work?

Diya Malhotra is Principal at Abingworth.

What does Diya Malhotra invest in?

Diya Malhotra invests in Biotech.

What check size does Diya Malhotra write?

Diya Malhotra typically writes checks of $15M – $30M.

Where did Diya Malhotra go to school?

Diya Malhotra studied at Imperial College London (Doctor of Philosophy (PhD), Neuroscience); University College London (BSc Pharmacology, Neuropharmacology); Overseas Family School Singapore (International Baccalaureate Diploma).

Diya Malhotra

Investor

Principal at Abingworth

London

Writes $15M – $30M checks · typically $22.5M

About

Diya Malhotra joined Abingworth in June 2021, having previously worked as a Consultant in L.E.K. Consulting's Life Sciences practice, where she advised pharmaceutical, biotech, and buyside clients on corporate strategy and clinical and commercial opportunity assessments. At Abingworth she works with the transatlantic investment team, particularly the Clinical Co-Development team, evaluating new opportunities and supporting existing investments. She holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.

Invests in

Biotech

Experience

AbingworthPrincipalcurrent2023 — presentGreater London, England, United Kingdom
AbingworthInvestment Manager2021 — 2023Greater London, England, United Kingdom
L.E.K. ConsultingLife Sciences Consultant2017 — 2021

Skills & more

R&D1Stem Cells1In Vivo1In Vitro1Pharmacology2NeuroscienceResearch3Drug DiscoveryTraumatic Brain InjuryCell Culture1miRNAPatents

+12 more

Intellectual PropertyNeuropharmacologyProject ManagementAnaestheticsPublic EngagementData HandlingOrganotypic Hippocampal Slice CultureRT-PCRMentoringFluorescence MicroscopyFluorescence SpectroscopyMicrosoft Office

From Diya's professional profile.

Colleagues at Abingworth

Alex Asquith

Counsel at Abingworth

Amit Khasgiwala

Investment Professional at Innovatus Capital Partners

Andrew Sinclair

Managing Director, Head of Publics & Late Stage at Abingworth

Ankur Shah

Vice President, CCD at Abingworth

Anna Slezak

Senior Associate at Abingworth

Bali Muralidhar

Global Head of Life Sciences & CIO at Abingworth

Carlos Paya

Venture Partner at Ysios Capital

Dayle Hogg

Operating Executive at Abingworth

Network5

Andrew Sinclair

Managing Director, Head of Publics & Late Stage at Abingworth

Bali Muralidhar

Global Head of Life Sciences & CIO at Abingworth

Genghis Lloyd-Harris

Senior Advisor at Abingworth

Jacqueline Grant

Principal at Abingworth

Jay Cui

Principal at Abingworth

Investors connected to Diya in public investor directories — a warm-intro map.

Frequently asked questions

Who is Diya Malhotra?: Diya Malhotra joined Abingworth in June 2021, having previously worked as a Consultant in L.E.K. Consulting's Life Sciences practice, where she advised pharmaceutical, biotech, and buyside clients on corporate strategy and clinical and commercial opportunity assessments. At Abingworth she works with the transatlantic investment team, particularly the Clinical Co-Development team, evaluating new opportunities and supporting existing investments. She holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.
Where does Diya Malhotra work?: Diya Malhotra is Principal at Abingworth.
What does Diya Malhotra invest in?: Diya Malhotra invests in Biotech.
What check size does Diya Malhotra write?: Diya Malhotra typically writes checks of $15M – $30M.
Where did Diya Malhotra go to school?: Diya Malhotra studied at Imperial College London (Doctor of Philosophy (PhD), Neuroscience); University College London (BSc Pharmacology, Neuropharmacology); Overseas Family School Singapore (International Baccalaureate Diploma).

Same school

Also attended Imperial College London499

Deji SasegbonVP, Platform & Portfolio Operations at EchoVC Partners Madison LenormandInvestor at Daphni Pauline BoucherInvestor at Daphni Loubaba El AyoubiInvestor at Northzone Giovanni MariggiInvestor at Medicxi Francois PrinslooInvestor at Medicxi

+ 493 more

Also attended University College London396

Demis HassabisCo-founder & CEO of Google DeepMind André DuboisInvestor at Index Ventures Frédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire Ventures Marie FerriInvestor at Daphni Elena PantaziPartner & Head of Platform at Northzone

+ 390 more

Shared employers

Also worked at Abingworth18

Carlos PayaVenture Partner at Ysios Capital Sarah ShackeltonAdvisor at Delin Ventures Bali MuralidharGlobal Head of Life Sciences & CIO at Abingworth Kurt von EmsterManaging Partner at Abingworth Jayson PunwaniManaging Director, Head of Venture at Abingworth Andrew SinclairManaging Director, Head of Publics & Late Stage at Abingworth

+ 12 more

Also worked at L.E.K. Consulting141

Chris BischoffInvestment Team at General Catalyst Mattias LjungmanInvestor at Moonfire Ventures Jessica SchultzPartner at Northzone Francois PrinslooInvestor at Medicxi Miranda GuerreroExecutive Assistant at Sapphire Ventures Stacey HeroInvestor at Third Rock Ventures

+ 135 more